Executive record

William H. Rastetter, Ph.D.

Director at Dare Bioscience, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:william-h-rastetter-ph-dVersion: public-0As of: 2026-09-28

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Dr. Rastetter is Chair of Dare Bioscience's Board and serves as Chairman of Neurocrine Biosciences and Fate Therapeutics. He is co-founder and Chairman of San Diego Squared, a non-profit focused on STEM education. He previously served as Chairman of Illumina, interim CEO of Grail, and held executive positions at Biogen Idec and Idec Pharmaceuticals. He has extensive biotechnology industry experience and serves as advisor to Illumina Ventures.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. DARE DEF 14A director slate

    sec filing · Source published: Apr 24, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and machine learning experience reported in filings · Claim reviewed: May 15, 2026
    • Board role: Board role: Chair · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Compensation · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Apr 24, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Dare Bioscience, Inc. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Dare Bioscience, Inc. · Claim reviewed: May 15, 2026